Travere Therapeutics, Inc.TVTXNASDAQ
LOADING
|||
EV to Sales History
Valuation returning toward historical norms
Left:
||||
Enterprise value to sales ratio
Latest
7.36
Near historical average
Average (9y)
7.92
Historical baseline
Range
High:15.41
Low:4.30
CAGR
+1.3%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | 7.36 | +5.5% |
| 2023 | 6.98 | -54.7% |
| 2022 | 15.41 | +4.0% |
| 2021 | 14.82 | +102.0% |
| 2020 | 7.34 | +70.7% |
| 2019 | 4.30 | -31.4% |
| 2018 | 6.27 | +27.4% |
| 2017 | 4.92 | -6.6% |
| 2016 | 5.27 | -19.5% |
| 2015 | 6.54 | - |